Protein-Based Nanomedicine Platforms for Drug Delivery

被引:419
作者
MaHam, Aihui [1 ]
Tang, Zhiwen [1 ]
Wu, Hong [1 ]
Wang, Jun [1 ]
Lin, Yuehe [1 ]
机构
[1] Pacific NW Natl Lab, Richland, WA 99352 USA
关键词
drug-delivery systems; nanomedicine; protein cages; tumors; HEAT-SHOCK-PROTEIN; COWPEA MOSAIC-VIRUS; METASTATIC BREAST-CANCER; ALBUMIN-BOUND PACLITAXEL; IN-VIVO EVALUATION; METHANOCOCCUS-JANNASCHII; TUMOR VASCULATURE; CONTRAST AGENTS; BUILDING-BLOCKS; PHAGE DISPLAY;
D O I
10.1002/smll.200801602
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Protein-based nanomedicine platforms for drug delivery comprise naturally self-assembled protein subunits of the same protein or a combination of proteins making up a complete system. They are ideal for drug-delivery platforms due to their biocompatibility and biodegradability coupled with low toxicity. A variety of proteins have been used and characterized for drug-delivery systems, including the ferritin/apoferritin protein cage, plant-derived viral capsids, the small Heat shock protein (sHsp) cage, albumin, soy and whey protein, collagen, and gelatin. There are many different types and shapes that have been prepared to deliver drug molecules using protein-based platforms, including various protein cages, microspheres, nanoparticles, hydrogels, films, minirods, and minipellets. The protein cage is the most newly developed biomaterial for drug delivery and therapeutic applications. The uniform size, multifunctionality, and biodegradability push it to the frontier of drug delivery. In. this Review, the recent strategic development of drug delivery is discussed with emphasis on polymer-based, especially protein-based, nanomedicine platforms for drug delivery. The advantages and disadvantages are also discussed for each type of protein-based drug-delivery system.
引用
收藏
页码:1706 / 1721
页数:16
相关论文
共 138 条
  • [1] ADLERMOORE J, 1994, BONE MARROW TRANSPL, V14, pS3
  • [2] Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO
  • [3] 2-P
  • [4] Ajani JA, 2000, CANCER J, V6, P78
  • [5] Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents
    Allen, M
    Bulte, JWM
    Liepold, L
    Basu, G
    Zywicke, HA
    Frank, JA
    Young, M
    Douglas, T
    [J]. MAGNETIC RESONANCE IN MEDICINE, 2005, 54 (04) : 807 - 812
  • [6] Constrained synthesis of cobalt oxide nanomaterials in the 12-subunit protein cage from Listeria innocua
    Allen, M
    Willits, D
    Young, M
    Douglas, T
    [J]. INORGANIC CHEMISTRY, 2003, 42 (20) : 6300 - 6305
  • [7] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [8] Ligand-targeted therapeutics in anticancer therapy
    Allen, TM
    [J]. NATURE REVIEWS CANCER, 2002, 2 (10) : 750 - 763
  • [9] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
    Arap, W
    Pasqualini, R
    Ruoslahti, E
    [J]. SCIENCE, 1998, 279 (5349) : 377 - 380
  • [10] RESONANCE ENERGY-TRANSFER AND FLUORESCENCE INTENSITY STUDIES OF THE TRANSPORT OF LIPOSOME-ENCAPSULATED MOLECULES INTO ISOLATED MOUSE-LIVER NUCLEI
    ARVINTE, T
    WAHL, P
    NICOLAU, C
    [J]. BIOCHEMISTRY, 1987, 26 (03) : 765 - 772